186 related articles for article (PubMed ID: 21947489)
1. Effect of the Honan intraocular pressure reducer on intraocular pressure increase following intravitreal injection using the tunneled scleral technique.
Kim KS; Jee D
Jpn J Ophthalmol; 2011 Nov; 55(6):632-7. PubMed ID: 21947489
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Honan intraocular pressure reducer to prevent vitreous reflux after intravitreal bevacizumab injection.
Hong SW; Jee D
Eur J Ophthalmol; 2012; 22(4):615-9. PubMed ID: 22562298
[TBL] [Abstract][Full Text] [Related]
3. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs.
Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA
Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353
[TBL] [Abstract][Full Text] [Related]
4. Impact of injection techniques on intraocular pressure (IOP) increase after intravitreal ranibizumab application.
Höhn F; Mirshahi A
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1371-5. PubMed ID: 20407785
[TBL] [Abstract][Full Text] [Related]
5. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections.
Frenkel MP; Haji SA; Frenkel RE
Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Honan intraocular pressure reducer in sub-Tenon's anesthesia.
Vallance JH; Patton N; Ferguson A; Bennett HG
J Cataract Refract Surg; 2004 Feb; 30(2):433-6. PubMed ID: 15030837
[TBL] [Abstract][Full Text] [Related]
7. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry.
Fuest M; Kotliar K; Walter P; Plange N
Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161
[TBL] [Abstract][Full Text] [Related]
8. Sustained elevation of intraocular pressure after intravitreal injections of bevacizumab in eyes with neovascular age-related macular degeneration.
Mathalone N; Arodi-Golan A; Sar S; Wolfson Y; Shalem M; Lavi I; Geyer O
Graefes Arch Clin Exp Ophthalmol; 2012 Oct; 250(10):1435-40. PubMed ID: 22434210
[TBL] [Abstract][Full Text] [Related]
9. Necessity of the Honan intraocular pressure reducer in cataract surgery using topical anesthesia.
Black EH; Cohen KL; Tripoli NK; Winslow PA
J Cataract Refract Surg; 1999 Feb; 25(2):223-6. PubMed ID: 9951668
[TBL] [Abstract][Full Text] [Related]
10. Tunnelled versus straight intravitreal injection: intraocular pressure changes, vitreous reflux, and patient discomfort.
Knecht PB; Michels S; Sturm V; Bosch MM; Menke MN
Retina; 2009 Sep; 29(8):1175-81. PubMed ID: 19734766
[TBL] [Abstract][Full Text] [Related]
11. Angled transscleral intravitreal injection: a crossover study.
Mehta MC; Finger PT
Eur J Ophthalmol; 2015; 25(2):173-6. PubMed ID: 25384968
[TBL] [Abstract][Full Text] [Related]
12. Clinical predictors of sustained intraocular pressure elevation due to intravitreal anti-vascular endothelial growth factor therapy.
Hoang QV; Tsuang AJ; Gelman R; Mendonca LS; Della Torre KE; Jung JJ; Freund KB
Retina; 2013 Jan; 33(1):179-87. PubMed ID: 22990314
[TBL] [Abstract][Full Text] [Related]
13. Hypotensive efficacy of topical brimonidine for intraocular pressure spikes following intravitreal injections of antivascular endothelial growth factor agents: a randomised crossover trial.
Felfeli T; Hostovsky A; Trussart R; Yan P; Brent MH; Mandelcorn ED
Br J Ophthalmol; 2019 Oct; 103(10):1388-1394. PubMed ID: 30573499
[TBL] [Abstract][Full Text] [Related]
14. Major factors affecting intraocular pressure spike after intravitreal ranibizumab injection: Vitreous reflux and its amount.
Uyar E; Ulas F; Sahin S; Celebi S
Eur J Ophthalmol; 2019 Jul; 29(4):361-367. PubMed ID: 30947538
[TBL] [Abstract][Full Text] [Related]
15. Intraocular Pressure in Eyes Receiving Intravitreal Antivascular Endothelial Growth Factor Injections.
Lemos V; Cabugueira A; Noronha M; Abegão Pinto L; Reina M; Branco J; Gomes T
Ophthalmologica; 2015; 233(3-4):162-8. PubMed ID: 25791262
[TBL] [Abstract][Full Text] [Related]
16. Short-term effects of intravitreal bevacizumab on cornea and anterior chamber.
Güler M; Capkın M; Simşek A; Bilak S; Bilgin B; Hakim Reyhan A; Fırat M
Curr Eye Res; 2014 Oct; 39(10):989-93. PubMed ID: 24588314
[TBL] [Abstract][Full Text] [Related]
17. Effect of antiglaucoma agents on short-term intraocular pressure fluctuations after intravitreal bevacizumab injections.
Shoeibi N; Ghosi Z; Jafari H; Omidtabrizi A
Int Ophthalmol; 2021 Mar; 41(3):1081-1090. PubMed ID: 33389369
[TBL] [Abstract][Full Text] [Related]
18. Persistent elevation of intraocular pressure following intravitreal injection of bevacizumab.
Segal O; Ferencz JR; Cohen P; Nemet AY; Nesher R
Isr Med Assoc J; 2013 Jul; 15(7):352-5. PubMed ID: 23943979
[TBL] [Abstract][Full Text] [Related]
19. Incidence and management of elevated intraocular pressure with antivascular endothelial growth factor agents.
Abedi G; Adelman RA; Salim S
Semin Ophthalmol; 2013 May; 28(3):126-30. PubMed ID: 23631423
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections].
El Chehab H; Le Corre A; Giraud JM; Ract-Madoux G; Swalduz B; Dot C
J Fr Ophtalmol; 2012 Oct; 35(8):614-21. PubMed ID: 22832030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
